These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8914388)

  • 21. [The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Taga S; Ogawa K; Nakagawa T; Tano M
    Kekkaku; 2005 Jan; 80(1):1-7. PubMed ID: 15839056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nontuberculous mycobacteriosis; the present status of epidemiology and clinical studies].
    Sakatani M
    Kekkaku; 1999 Apr; 74(4):377-84. PubMed ID: 10355224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multidrug-resistant tuberculosis. 4. Treatment and prognosis of multidrug-resistant tuberculosis].
    Ogawara M; Sakatani M
    Kekkaku; 1998 Nov; 73(11):673-7. PubMed ID: 9866930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative study of pulmonary disease due to Mycobacterium avium and M. intracellulare identified by a newly developed DNA probe (Gen-Probe].
    Mizutani S
    Kekkaku; 1991 Jan; 66(1):19-38. PubMed ID: 2013966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary infection type atypical mycobacteriosis (lung infection) in the Fuji City Central Hospital during 1989-94].
    Imaizumi T
    Kekkaku; 1997 Jun; 72(6):415-21. PubMed ID: 9248276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
    Yamamoto S; Toida I; Watanabe N; Ura T
    Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of INH and RFP-resistant refractory tuberculosis].
    Kekkaku; 1991 Oct; 66(10):687-706. PubMed ID: 1960917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
    Wada M; Seita A; Mori T; Ogata H; Sugie T; Sugita H
    Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of pulmonary nontuberculous mycobacteriosis].
    Kurashima A
    Kekkaku; 2002 Dec; 77(12):815-21. PubMed ID: 12607341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimycobacterial activities of rifamycin derivatives].
    Kuze F
    Kekkaku; 1991 Oct; 66(10):679-85. PubMed ID: 1960916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
    Sato K; Tomioka H
    Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapeutic regimens that were considered effective to cure pulmonary infection caused by Mycobacterium avium-Mycobacterium intracellulare complex].
    Tsukamura M
    Kekkaku; 1991 May; 66(5):375-80. PubMed ID: 1875580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The short-term effects of multidrug chemotherapy for pulmonary Mycobacterium avium-intracellulare complex (MAC) infection].
    Kurashima A
    Kekkaku; 1998 May; 73(5):371-7. PubMed ID: 9637822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of 41 cases of pulmonary atypical mycobacteriosis].
    Xia XX
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):200-1, 253. PubMed ID: 1307510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.